title: Optimal dosing of high-dose melphalan prior to autologous hematopoietic stem cell transplantation in a patient with AL amyloidosis and a solitary kidney.
authors: Amyloidosis Center, Department of Medicine, Boston University School of Medicine, Boston Medical Center, Boston, MA, USA; Section of Hematology/Oncology, Department of Medicine, Boston University School of Medicine, Boston Medical Center, Boston, MA, USA.
authors: Shin Yin
authors: SY
authors: Lee
authors: Amyloidosis Center, Department of Medicine, Boston University School of Medicine, Boston Medical Center, Boston, MA, USA; Section of Hematology/Oncology, Department of Medicine, Boston University School of Medicine, Boston Medical Center, Boston, MA, USA.
authors: Dina
authors: D
authors: Brauneis
authors: Amyloidosis Center, Department of Medicine, Boston University School of Medicine, Boston Medical Center, Boston, MA, USA; Section of Nephrology, Department of Medicine, Boston University School of Medicine, Boston Medical Center, Boston, MA, USA.
authors: Lauren
authors: L
authors: Stern
authors: Amyloidosis Center, Department of Medicine, Boston University School of Medicine, Boston Medical Center, Boston, MA, USA; Section of Hematology/Oncology, Department of Medicine, Boston University School of Medicine, Boston Medical Center, Boston, MA, USA. Electronic address: vaishali.sanchorawala@bmc.org.
authors: Vaishali
authors: V
authors: Sanchorawala
mesh_terms: D000686:Amyloidosis / Q000150:complications* / Q000188:drug therapy*; D003404:Creatinine / Q000097:blood; D004305:Dose-Response Relationship, Drug; D005919:Glomerular Filtration Rate; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007668:Kidney / Q000002:abnormalities*; D008558:Melphalan / Q000008:administration & dosage* / Q000627:therapeutic use*; D014182:Transplantation, Autologous
chemical_list: D003404:Creatinine; D008558:Melphalan